Literature DB >> 10744066

Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity.

N Teramoto1, A Maeda, K Kobayashi, K Hayashi, T Oka, K Takahashi, K Takada, G Klein, T Akagi.   

Abstract

Almost all nasopharyngeal carcinomas (NPCs) are infected by Epstein-Barr virus (EBV), but most ex vivo NPC cells lose EBV genomes during passages. In this study, an EBV-negative NPC cell line, TW03, established from EBV-carrying NPC was reinfected with EBV by cocultivation with irradiated Akata cells carrying recombinant EBV containing a neomycin-resistant gene. The reinfected EBV (+) TW03 cells expressed EBERs and EBNA1, but not EBNA2, lytic proteins (ZEBRA and EA-D), or LMP1. They had an epithelial appearance similar to that of EBV (-) TW03 cells. The doubling times of EBV (+) and EBV (-) TW03 cells were almost identical. However, the EBV (+) TW03 cells formed larger colonies with ragged contours in anchorage-independent cultures. An in vitro invasion assay showed that EBV (+) TW03 cells had a higher invasive activity than EBV (-) TW03 cells (p < 0.01). Both EBV (-) and EBV (+) TW03 cells formed poorly differentiated squamous cell carcinomas in SCID and nude mice. EBV (+) TW03 cells showed a higher tumorigenicity to nude mice (12 of 13) than EBV (-) TW03 cells (1 of 9) (p < 0.001). In the severe combined immunodeficiency (SCID) tumors of EBV (+) TW03 cells, not all of the tumor cells were EBER-1 positive. EBER-1 was more frequently detected in the peripheral regions and daughter nodules of the tumors than in the central areas. The microdissection polymerase chain reaction showed that the EBER-1-negative TW03 cells in the EBV (+) TW03 SCID tumors lost EBV genomes. EBER-1-negative cells showed as high a rate of Ki-67 positivity as EBER-1-positive cells, indicating that the former were proliferating rather than dead or dying. In horny pearls, keratinizing cells were ZEBRA-positive and EBER-negative. Loss of EBV genomes was not associated with squamous differentiation. These data indicated that reinfection of EBV promotes the tumorigenicity of EBV (-) TW03 cells by enhancing the invading activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744066     DOI: 10.1038/labinvest.3780035

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

1.  Themed issue: the biology and pathology of the Epstein-Barr virus.

Authors:  P G Murray; L S Young
Journal:  Mol Pathol       Date:  2000-10

2.  Redirecting tyrosine kinase signaling to an apoptotic caspase pathway through chimeric adaptor proteins.

Authors:  Perry L Howard; Marie C Chia; Suzanne Del Rizzo; Fei-Fei Liu; Tony Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

3.  Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells.

Authors:  Jiun-Han Lin; Ching-Hwa Tsai; Jan-Show Chu; Jeou-Yuan Chen; Kenzo Takada; Jin-Yuh Shew
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

4.  Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma.

Authors:  Yuan-Chii Gladys Lee; Yu-Chyi Hwang; Kuang-Chi Chen; Yong-Shiang Lin; Dah-Yeou Huang; Tao-Wei Huang; Cheng-Yan Kao; Han-Chung Wu; Chin-Tarng Lin; Chi-Ying F Huang
Journal:  Funct Integr Genomics       Date:  2006-09-19       Impact factor: 3.410

5.  Modeling nasopharyngeal carcinoma in three dimensions.

Authors:  Prabu Siva Sankar; Mohd Firdaus Che Mat; Kalaivani Muniandy; Benedict Lian Shi Xiang; Phang Su Ling; Susan Ling Ling Hoe; Alan Soo-Beng Khoo; Nethia Mohana-Kumaran
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

6.  Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line.

Authors:  Jun Nishikawa; Lorand L Kis; Anquan Liu; Xiangning Zhang; Miki Takahara; Kentaro Bandobashi; Csaba Kiss; Noemi Nagy; Kiwamu Okita; George Klein; Eva Klein
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

Review 7.  Epstein-Barr virus latent genes.

Authors:  Myung-Soo Kang; Elliott Kieff
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

8.  The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.

Authors:  Lielian Zuo; Haibo Yu; Lingzhi Liu; Yunlian Tang; Hongzhuan Wu; Jing Yang; Meijuan Zhu; Shujuan Du; Lian Zhao; Li Cao; Guiyuan Li; Jianhong Lu
Journal:  Oncotarget       Date:  2015-12-01

9.  Epstein-Barr virus stably confers an invasive phenotype to epithelial cells through reprogramming of the WNT pathway.

Authors:  Christine E Birdwell; Kanchanjunga Prasai; Samantha Dykes; Yali Jia; Tawsha G C Munroe; Malgorzata Bienkowska-Haba; Rona S Scott
Journal:  Oncotarget       Date:  2018-01-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.